OOIR: Observatory of International Research

Papers

(The TQCC of JAMA Psychiatry is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	931
Potential Limitations for Assessing Adverse Posttraumatic Neuropsychiatric Sequelae With Wrist-Wearable Device and Self-report Survey	526
Assumptions and Limitations of the Synthetic Control Method	376
Error in Results	326
Further Considerations on Early Intervention for Borderline Personality Disorder—Reply	252
JAMA Psychiatry	246
An Opportunity to Advance Cannabis Science—DEA Rescheduling	243
Potential Lessons for DSM From Contemporary Philosophy of Science	230
Overmystifying the Psychedelic Experience	218
JAMA Psychiatry	191
Polygenic Contributions to Lithium Augmentation Outcomes in Unipolar Depression	191
Integrating Financing Variables Into Behavioral Health Policy Implementation Research	183
Brief Cognitive Behavioral Therapy for Suicidal Military Personnel and Veterans	182
JAMA Psychiatry	182
The Reliability of Traumatic and Adverse Experiences	169
Left Ventrolateral Prefrontal Cortical Activity During Reward Expectancy and Mania Risk	166
Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	155
Managerial and Organizational Challenges in the Age of AI	138
Issues in Clinical Trial Design—Lessons From the FDA’s Rejection of MDMA	137
Consistency of Delusion Themes Across First and Subsequent Episodes of Psychosis	133
Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy	129
Diagnosing and Treating ADHD in Adults	127
TikTok Challenges—Unintentional Injuries vs Suicide Attempts	125
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias	124
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders	123

Neighborhood Disadvantage and Autism Spectrum Disorder in a Population With Health Insurance	121
Error in Abstract	118
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women	117
Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression	116
Associations Between Objective and Subjective Experiences of Childhood Maltreatment and the Course of Emotional Disorders in Adulthood	115
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	113
Errors in Figures 1 and 2	111
JAMA Network Call for Papers on Health and the 2024 US Election	110
JAMA Psychiatry	108
JAMA Psychiatry	105
Error in the Caption of Figures 2, 3, 4, and 5 and in Supplement 1	102
Error in Byline	100
Effect of a Tobacco Cessation Intervention Incorporating Weight Management for Adults With Serious Mental Illness	98
Searching the Brain for the Cause of Psychosis	96
Mental Health Impairment and Outpatient Mental Health Care of US Children and Adolescents	95
Risk for Mood, Anxiety, and Psychotic Disorders in Individuals at High and Low Genetic Liability for Bipolar Disorder and Major Depression	95
US Veterans Affairs and Department of Defense 2023 Clinical Guideline for PTSD—Devolving Not Evolving	94
Addiction Medicine Physicians and Medicinal Cannabinoids	92
Living Alone and Drug Overdose Deaths in the US	92
Association of Frailty With Risk of Suicide Attempt in a National Cohort of US Veterans Aged 65 Years or Older	89
Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth	89
Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction	88
Hyperalgesia in Patients With a History of Opioid Use Disorder	87
The Role of Energy Homeostasis in Depression Pathophysiology and Its Heterogeneity	85
Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression	84
Evaluation of Post–COVID-19 Cognitive Dysfunction: Recommendations for Researchers	82
Perinatal Mental Health Outcomes Following Natural Disasters	80
JAMA Psychiatry—The Year in Review, 2021	78
Errors in Figures 3, 4, and 5	78
Associating Violence With Schizophrenia—Risks and Biases—Reply	78
COVID-19 and Mental Health in Young People—Causality or Co-occurrence?	78
Etiologic Studies of Premenstrual Disorders Require Prospective Confirmation of Affective Cyclicity	77
JAMA Psychiatry	76
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	75
Limitations for Assessing Optimism and Physical Functioning in Women—Reply	75
Expanding Current Approaches to Solve the Opioid Crisis	74
Measures of General Intelligence and Risk for Alcohol Use Disorder	73
JAMA Psychiatry	72
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19?—Reply	72
Physician Suicide and Associated Features—What Defines a Physician?	72
Implementation Strategies Used and Reported in Brief Suicide Prevention Intervention Studies	71
Adjuvant Psychotherapies to Prevent Relapse in Bipolar Disorder	68
Trends in Outpatient Psychotherapy Among Adults in the US	68
War Exposure and DNA Methylation in Syrian Refugee Children and Adolescents	68
Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression	68
Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar Disorder	68
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs	66
Psychosis Spectrum Symptoms Before and After Adolescent Cannabis Use Initiation	66
Neurobiological, Psychosocial, and Behavioral Mechanisms Mediating Associations Between Physical Activity and Psychiatric Symptoms in Youth in the Netherlands	65
Evaluation of a Model to Target High-risk Psychiatric Inpatients for an Intensive Postdischarge Suicide Prevention Intervention	64

Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study	64
Sweetened Beverages and Incident All-Cause Dementia Among Older Adults	62
Social Determinants of Health and Suicide-Related Outcomes	61
Stratified Care vs Stepped Care for Depression	61
Error in Figure 2	60
Errors in Author Affiliations, Table, and Figure 3	59
Suicide Risk—A Specific Intervention Target	59
Errors in Text, Tables, and Figure	59
Reducing the Risks of Nuclear War	59
Do Not Rule Out Double-blind Placebo Run-in Periods for Randomized Clinical Trials	57
Association of Receipt of Opioid Use Disorder–Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19	56
Etiologic Studies of Premenstrual Disorders Require Prospective Confirmation of Affective Cyclicity—Reply	56
Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021	55
A Case for Permanent Adoption of Expanded Telehealth Services and Prescribing Flexibilities for Opioid Use Disorder	55
Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk	55
All-Cause and Cause-Specific Mortality Among Individuals With Hypochondriasis	53
Association Between Failures in Perceptual Updating and the Severity of Psychosis in Schizophrenia	52
GLP-1 Receptor Agonists for Pharmacologically Induced Weight Gain	52
Right-Based Mental Health Care—Advantages of Tax-Financed Universal Mental Health Care	52
JAMA Psychiatry	52
Rural and Urban Trends in Mental Health Readmissions	51
The Rapid Rise in Investment in Psychedelics—Cart Before the Horse	51
Ultrarare Coding Variants and Cognitive Function in Schizophrenia	51
Treating Bipolar Depression Using Psilocybin—Validity Threats Regarding Efficacy and Safety	50
Written Exposure Therapy Finds Solid Footing Alongside First-Line Psychotherapies for Posttraumatic Stress Disorder	50
The Need for Functional Assessments in School-Based Mental Health Intervention Research	50
Psychomotor Slowing in Psychosis and Inhibitory Repetitive Transcranial Magnetic Stimulation	50
Lifetime Suicide Attempts in Otherwise Psychiatrically Healthy Individuals	49
Assessment of Disruptive Life Events for Individuals Diagnosed With Schizophrenia or Bipolar I Disorder Using Data From a Consumer Credit Reporting Agency	49
Brexpiprazole and Sertraline Combination Treatment in Posttraumatic Stress Disorder	49
Loss of PTSD Diagnosis in Response to Evidence-Based Treatments	49
Brief Cognitive Behavioral Therapy for Suicidal Inpatients	49
Genetic and Phenotypic Features of Schizophrenia in the UK Biobank	49
Prospective and Retrospective Measures of Child Maltreatment and Their Association With Psychopathology	48
Emotional Experience of People With Schizophrenia and People at Risk for Psychosis	48
Association of Ambient Temperature With the Prevalence of Intimate Partner Violence Among Partnered Women in Low- and Middle-Income South Asian Countries	46
Racial and Ethnic Disparities in Buprenorphine Treatment Duration in the US	46
Adverse Childhood Experiences and Mental Distress Among US Adults by Sexual Orientation	46
Bright Light Therapy as Add-On to Inpatient Treatment in Youth With Moderate to Severe Depression	46
JAMA Psychiatry	45
Cognitive Behavior Therapy for Mental Disorders in Adults	45
Sex Differences in Autism Heritability and Likelihood	45
Genetic Liability to Posttraumatic Stress Disorder Symptoms and Its Association With Cardiometabolic and Respiratory Outcomes	44
Errors in Byline and Abstract	44
Transdisciplinary Science and Research Training in Psychiatry	44
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency	44
Error in Title of Figure 1	44
Errors in Results and Tables	44
JAMA Psychiatry—The Year in Review 2024	42
Integrated Nicotine Replacement and Behavioral Support to Reduce Smoking in Opioid Agonist Therapy	42
JAMA Psychiatry	42
Toward 90-90-90 Goals for Global Mental Health	42
Effect of General Practitioner Training in a Collaborative Child Mental Health Care Program on Children’s Mental Health Outcomes in a Low-Resource Setting	41
Implementing Precision Medicine in Psychiatry	41
VA/Department of Defense Clinical Practice Guideline for PTSD and ASD	41
Physician Suicide and Associated Features—What Defines a Physician?—Reply	41
From Static to Dynamic Prediction of Suicide Risk	40
Striatal Activity to Reward Anticipation as a Moderator of the Association Between Early Behavioral Inhibition and Changes in Anxiety and Depressive Symptoms From Adolescence to Adulthood	40
Preexisting Neuropsychiatric Conditions and Associated Risk of Severe COVID-19 Infection and Other Acute Respiratory Infections	40
Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis	39
Enough to Promote Changes to Current Management of Catatonia?	39
Intranasal Oxytocin and Physical Intimacy for Dermatological Wound Healing and Neuroendocrine Stress	39
Precision Assignment to Psychosocial Interventions for Late-Life Depression	39
The Course of General Cognitive Ability in Individuals With Psychotic Disorders	39
Acupuncture for Combat-Related Posttraumatic Stress Disorder	39
Functional vs Structural Cortical Deficit Pattern Biomarkers for Major Depressive Disorder	38
Suicidal Ideation and Suicide Attempts After Direct or Indirect Psychotherapy	38
Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape	38
Considerations Regarding Antipsychotic Drug Prescriptions Among People With Dementia During the COVID-19 Pandemic	37
Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression	37
Potential of Control Conditions for Nonspecific Treatment-Effects in Noninferiority Trials—Reply	37
Antipsychotic Monotherapy vs Polytherapy for Pneumonia Risk—Reply	36
Combination Antidepressant Therapy vs Monotherapy—Further Considerations—Reply	36
JAMA Psychiatry	36
Complex Interaction of Lithium With Kidney and Bone Health	36
Understanding Placebo Mechanisms to Reduce Attrition in Psychiatric Trials	35
Informant Effect on Placebo Response in Mental Disorders—Reply	35
Psilocybin in Bipolar II Study Provides Preliminary Data on Safety	35
Prescription Stimulant Prescribing, Nonmedical Use, and Shortages	35
Error in Figure 1	35

Error in Figure	35
JAMA Psychiatry	35
Associations Between Early Life Adversity, Reproduction-Oriented Life Strategy, and Borderline Personality Disorder	34
Investing in a Research Workforce With Personal Experience of Serious Mental Illness	34
Stimulant Use Disorder Diagnoses in Adolescent and Young Adult Medicaid Enrollees	34
Effects of a Smartphone-Based Self-management Intervention for Individuals With Bipolar Disorder on Relapse, Symptom Burden, and Quality of Life	34
Telehealth Mindfulness-Oriented Recovery Enhancement vs Usual Care in Individuals With Opioid Use Disorder and Pain	33
Female Physician Suicide Compared to the General Population	33
Issues With Person-Time and Repetitive Event Calculation	33
Association of Cardiovascular Health With Risk of Clinically Relevant Depressive Symptoms	33
Heart Rate Variability Biofeedback for Substance Use Disorder	33
Why Hippocampal Glutamate Levels Are Elevated in Schizophrenia	33
Short-Term Trials Underestimate Antidepressant Withdrawal—Reply	33
Processing Speed Impairment in Schizophrenia	32
Brain Morphometry Normative Modeling—Omit Global Thickness—Reply	32
RETRACTED: Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis	32
COVID-19 and Risk for Mental Disorders Among Adults in Denmark	32
Mental Health Treatment Gap—The Implementation Problem as a Research Problem	31
Differences in Insurance Coverage for Individuals With Schizophrenia After Implementation of the Patient Protection and Affordable Care Act	31
Effect of Technology-Enhanced Screening in Addition to Standard Targeted Clinician Education on the Duration of Untreated Psychosis	31
Written Exposure Therapy vs Prolonged Exposure Therapy in the Treatment of Posttraumatic Stress Disorder	31
Functional Connectivity of the Nucleus Accumbens and Changes in Appetite in Patients With Depression	31
Substance Use Disorder and Health Outcomes in COVID-19—The Need for a Better Research Method to Determine Substance Use Exposure—Reply	30
COP27 Climate Change Conference—Urgent Action Needed for Africa and the World	30
Mental Health Care Support in Rural India	30
Coding Error for the Sex Variable in a Meta-analysis	30
Transcriptome-Wide Structural Equation Modeling of 13 Major Psychiatric Disorders for Cross-Disorder Risk and Drug Repurposing	29
Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression	29
Inflammatory Exposure and Depression in Older Adults With Insomnia	29
Lessons Learned From Drug Decriminalization Remedies in British Columbia	29
Cannabis Use Among Individuals With Psychosis After State-Level Commercial Cannabis Legalization	29
Antipsychotic Acute-Phase Treatment in Individuals With and Without Recent Treatment	29
International Variation in Clozapine Hematologic Monitoring—A Call for Action	29
Issues With Person-Time and Repetitive Event Calculation—Reply	29
Posttraumatic Stress Disorder, Obesity, and Accelerated Epigenetic Aging Among US Military Veterans	29
Change Patterns of Posttraumatic and Grief Disorders and Their Somatic Variables in Ongoing Trauma	28
Substance Use Disorder and Health Outcomes in COVID-19—The Need for a Better Research Method to Determine Substance Use Exposure	28
Preaddiction—A Missing Concept for Treating Substance Use Disorders	27
Over-the-Counter Naltrexone to Address Unhealthy Alcohol Use	27
Alcohol Cue Processing in Co-Occurring Bipolar Disorder and Alcohol Use Disorder	27
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia	27
Distinct Convergent Brain Alterations in Sleep Disorders and Sleep Deprivation	26
Patterns of Brain Maturation in Autism and Their Molecular Associations	26
Association of Oxidative Stress–Induced Nucleic Acid Damage With Psychiatric Disorders in Adults	26
Depression Associated With Hormonal Contraceptive Use as a Risk Indicator for Postpartum Depression	26
Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders	26
Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials	26
Reporting and Representation of Race and Ethnicity in Clinical Trials of Pharmacotherapy for Mental Disorders	26
Estimated Number of Children Who Lost a Parent to Drug Overdose in the US From 2011 to 2021	26
Association of 24-Hour Activity Pattern Phenotypes With Depression Symptoms and Cognitive Performance in Aging	26
Change to Open Access Status	26
Data-Driven Contingency Management Incentive Magnitudes	26
JAMA Psychiatry Peer Reviewers in 2021	25
Error in Results and in the Figure 3B Label and Plotted Values	25
Long-term Arrhythmia Detection Using an Implantable Loop Recorder in Patients Receiving Psychotropic Medication	25
Psychopharmacologic Considerations for Transgender and Gender Diverse People	25
Timing of Antidepressant Discontinuation During Pregnancy and Postpartum Psychiatric Outcomes in Denmark and Norway	25
Dissimilar Control Interventions in Clinical Trials Undermine Interpretability—Reply	25
JAMA Psychiatry Editorial Fellow	25
Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity Disorder	24
Social Disconnection as a Global Behavioral Epidemic—A Call to Action About a Major Health Risk Factor	24
Value-Based Payment and Behavioral Health	24
Evolutionary Inquiries Into the Origin and Nature of Mental Disorders	24
Mental Health Service Use Before First Diagnosis of a Psychotic Disorder	24
Neuropsychiatric Ramifications of Severe COVID-19 and Other Severe Acute Respiratory Infections	24
Cognitive Function in People With Familial Risk of Depression	24
Notice of Retraction: Worthington MA et al. Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis: A Joint Modeling Approach. JAMA Psychiatry. 2023;80(10):1017-1025.	24
Antipsychotic Medications and Mortality in Children and Young Adults	24
Clinician Suicide Risk Assessment for Prediction of Suicide Attempt in a Large Health Care System	24
An Atlas of Genetic Correlations and Genetically Informed Associations Linking Psychiatric and Immune-Related Phenotypes	23
Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation	23
Errors in Network Meta-Analysis of Generalized Anxiety Disorder Psychotherapies	23
Clinical Outcomes of Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	23
Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia, Bipolar Disorder, and Depression Among Adults in the US Veterans Affairs Health Care System	23
Change to Open Access Status	23
Antidepressant Use and Manic Episodes in Children and Adolescents With Unipolar Depression	23
Suicidality Calls to a National Helpline After a Terror Attack and War	23
Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia	23
Error in Figure 2	23
Association Between Physical Activity and Risk of Depression	23
JAMA Psychiatry	22
Gratitude and Mortality Among Older US Female Nurses	22
Promoting Social Prescribing in Psychiatry—Using Shared Decision-Making and Peer Support	22
National Data on Age Gradients in Well-being Among US Adults	22
Error in Display of Author Name	22
Addressing the Escalating Problems That Patients Encounter When Filling Buprenorphine Prescriptions	22
Parental Mental Disorders and Offspring Mortality up to Middle Age	22
SSRIs in Pregnancy—What Offspring Brain Volumes Can and Cannot Tell Us—Reply	22
Years of Life Lost to Drug Overdose Among Black Female Individuals in the US, 2015-2021	22
Error in Figure Caption	22
Esketamine Combined With SSRI or SNRI for Treatment-Resistant Depression	22
Grief-Specific Cognitive Behavioral Therapy vs Present-Centered Therapy	21
Transmission of Mental Disorders in Adolescent Peer Networks	21
Anorexia Nervosa—Facts, Frustrations, and the Future	21
Efficacy of Adjunctive D-Cycloserine to Intermittent Theta-Burst Stimulation for Major Depressive Disorder	21